Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026

'Chancellor John Healey's Budget will reveal winners and losers as hope meets reality next month'

28 September 2026

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

28 September 2026
Facebook X (Twitter) Instagram
Business Monday, Sep 28
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » PDD Holdings: The Market Prices In Almost No Growth (NASDAQ:PDD)
News

PDD Holdings: The Market Prices In Almost No Growth (NASDAQ:PDD)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk17 July 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
PDD Holdings: The Market Prices In Almost No Growth (NASDAQ:PDD)
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

I’m a passionate investor from the Netherlands with 12 years of stock market experience. My articles usually contain a good overview of important investment criteria. A stock for my portfolio is of interest to me if the company has the following characteristics:1. Companies that are growing in both revenue, earnings and free cash flow.2. Companies that have excellent growth prospects.3. Stocks with favorable valuations.I prefer steadily growing companies with high free cash flow margins, dividend stocks and stocks with generous share repurchase programs.Disclaimer: My articles do not provide financial advice, they reflect my own findings and insights.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

Kinross Gold: The Pullback I Waited For Came With Damage Attached (NYSE:KGC)

Dividend Announcements: September 19-25, 2026

I Demand A Monthly Paycheck From My Portfolio; +7.5% Yields

Viemed Healthcare: Improving Capital Efficiency Creates A Strong Buy Opportunity (NASDAQ:VMD)

Editors Picks

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026

'Chancellor John Healey's Budget will reveal winners and losers as hope meets reality next month'

28 September 2026

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

28 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

28 September 2026

Kinross Gold: The Pullback I Waited For Came With Damage Attached (NYSE:KGC)

28 September 2026

Dividend Announcements: September 19-25, 2026

28 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.